|
GB9919413D0
(en)
|
1999-08-18 |
1999-10-20 |
Zeneca Ltd |
Chemical compounds
|
|
WO2001032621A1
(en)
*
|
1999-10-29 |
2001-05-10 |
Wakunaga Pharmaceutical Co., Ltd. |
Novel indole derivatives and drugs containing the same as the active ingredient
|
|
CN100540538C
(zh)
*
|
2001-04-16 |
2009-09-16 |
田边三菱制药株式会社 |
高传导率钙-活化k通道开启剂
|
|
AU2002323776B2
(en)
|
2001-08-10 |
2008-07-31 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator-responsive receptor Delta
|
|
JP4276074B2
(ja)
|
2001-10-12 |
2009-06-10 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体δの活性化剤
|
|
EP1771169A1
(en)
*
|
2004-07-14 |
2007-04-11 |
PTC Therapeutics, Inc. |
Methods for treating hepatitis c
|
|
KR20070091607A
(ko)
*
|
2004-10-12 |
2007-09-11 |
디코드 제네틱스, 아이엔씨. |
폐쇄성 동맥 질환용의 설폰아미드 주변 치환된바이사이클릭 화합물
|
|
WO2006046683A1
(en)
*
|
2004-10-25 |
2006-05-04 |
Astellas Pharma Inc. |
Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists
|
|
US7977359B2
(en)
|
2005-11-04 |
2011-07-12 |
Amira Pharmaceuticals, Inc. |
5-lipdxygenase-activating protein (FLAP) inhibitors
|
|
US8399666B2
(en)
|
2005-11-04 |
2013-03-19 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
GB2431927B
(en)
*
|
2005-11-04 |
2010-03-17 |
Amira Pharmaceuticals Inc |
5-Lipoxygenase-activating protein (FLAP) inhibitors
|
|
CA2642668C
(en)
*
|
2006-02-15 |
2013-01-08 |
Allergan, Inc. |
Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity
|
|
CN101460458A
(zh)
*
|
2006-02-15 |
2009-06-17 |
阿勒根公司 |
具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
|
|
ZA200809148B
(en)
|
2006-04-18 |
2010-01-27 |
Nippon Chemiphar Co |
Activating agent for peroxisome proliferator activated receptor delta
|
|
DE102006021733A1
(de)
*
|
2006-05-09 |
2007-11-22 |
Bayer Healthcare Ag |
3-Tetrazolylindazole und 3-Tetrazolylpyrazolopyridine sowie ihre Verwendung
|
|
EP2027117A2
(en)
*
|
2006-05-16 |
2009-02-25 |
Decode Genetics EHF |
Process for preparing 7-(acryloyl)-indoles
|
|
DE102006043443A1
(de)
*
|
2006-09-15 |
2008-03-27 |
Bayer Healthcare Ag |
Neue aza-bicyclische Verbindungen und ihre Verwendung
|
|
US8524917B2
(en)
|
2007-01-11 |
2013-09-03 |
Allergan, Inc. |
6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
|
|
JP2010515750A
(ja)
*
|
2007-01-11 |
2010-05-13 |
アラーガン インコーポレイテッド |
スフィンゴシン−１−ホスフェート（ｓ１ｐ）受容体アンタゴニスト生物活性を有する６−置換インドール−３−カルボン酸アミド化合物
|
|
JP5474769B2
(ja)
|
2008-04-15 |
2014-04-16 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤活性化受容体の活性化剤
|
|
US8546431B2
(en)
|
2008-10-01 |
2013-10-01 |
Panmira Pharmaceuticals, Llc |
5-lipoxygenase-activating protein (FLAP) inhibitors
|
|
DE102008063992A1
(de)
|
2008-12-19 |
2010-09-02 |
Lerner, Zinoviy, Dipl.-Ing. |
Neue aliphatisch substituierte Pyrazolopyridine und ihre Verwendung
|
|
NZ601967A
(en)
|
2010-03-12 |
2015-03-27 |
Omeros Corp |
Pde10 inhibitors and related compositions and methods
|
|
CN106986862A
(zh)
|
2010-12-22 |
2017-07-28 |
Abbvie 公司 |
丙型肝炎抑制剂及其用途
|
|
AP2015008670A0
(en)
|
2013-02-21 |
2015-08-31 |
Adverio Pharma Gmbh |
Forms of methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-B]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate
|
|
NZ716462A
(en)
|
2014-04-28 |
2017-11-24 |
Omeros Corp |
Optically active pde10 inhibitor
|
|
NZ716494A
(en)
|
2014-04-28 |
2017-07-28 |
Omeros Corp |
Processes and intermediates for the preparation of a pde10 inhibitor
|
|
KR102586736B1
(ko)
*
|
2014-08-29 |
2023-10-11 |
씨에이치디아이 파운데이션, 인코포레이티드 |
헌팅틴을 단백질 영상화하기 위한 프로브
|
|
CN107530313A
(zh)
|
2015-04-24 |
2018-01-02 |
奥默罗斯公司 |
Pde10抑制剂以及相关组合物和方法
|
|
WO2017079678A1
(en)
|
2015-11-04 |
2017-05-11 |
Omeros Corporation |
Solid state forms of a pde10 inhibitor
|
|
AU2018367909B2
(en)
|
2017-11-17 |
2022-03-10 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of eye disorders
|